Author

A. Kollar

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Organism:non-human primate· 1

Frequent Co-Authors

A. Chouchane· 1 shared A. E. Loiselle· 1 shared A. E. Nichols· 1 shared A. Perren· 1 shared B. Wiedenmann· 1 shared C. A. Kunze· 1 shared C. Ketonis· 1 shared C. Statzer· 1 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Chouchane

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Epitenon-derived cells comprise a distinct progenitor population that contributes to both fibrosis and regeneration following acute flexor tendon injury in a spatially-dependent manner

A. E. Nichols, L. Benoodt, E. Adjei-Sowah, K. Jerreld, A. Kollar, C. Ketonis, A. E. Loiselle

bioRxiv · Jan 30, 2023 · PreprintCell Biology

Establishment of a Mycoplasma hyorhinis challenge model in five-week-old piglets

D. Foldi, E. Z. Nagy, N. Belecz, L. Szeredi, J. Foldi, A. Kollar, M. Tenk, Z. Kreizinger, M. Gyuranecz

This study compares two challenge routes for inducing Mycoplasma hyorhinis infection in piglets, finding that intravenous challenge causes more severe lesions and is more natural-like.

bioRxiv · Jan 17, 2023 · PreprintMicrobiology

Patient-derived tumoroids of advanced high-grade neuroendocrine neoplasms mimic patient chemotherapy responses and guide the design of personalized combination therapies

S. L. April-Monn, K. Detjen, P. Kirchner, K. Braeutigam, M. A. Trippel, T. Grob, C. Statzer, R. S. Maire, A. Kollar, A. Chouchane, C. A. Kunze, D. Horst, M. C. Sadowski, J. Schrader, I. Marinoni, , A. Perren

The paper develops patient-derived tumoroids to predict chemotherapy responses and identify synergistic drug combinations for high-grade GEP-NEN.

bioRxiv · Dec 10, 2022 · PreprintCancer Biology